Multicenter phase II study of a 28-day regimen of orally administered eniluracil and fluorouracil in the treatment of patients with anthracycline- and taxane-resistant advanced breast cancer.
暂无分享,去创建一个
G. Hortobagyi | L. Sutton | M. Somerville | D. Frye | M. Graham | E. Rivera | B. Colwell | J. Levin | C. McGuirt | H. S. Conklin